If you're taking an SSRI and considering GLP-1 therapy, understanding potential interactions and safety profiles is essential for making an informed treatment decision
The drugs protective effect against kidney disease provides more value due to their influence on renal health
Guanfacine | Drugs BNF NICE
The overall risk of digestive issues is generally similar across the semaglutide family
Exclusion criteria included any current or prior conditions affecting other bodily systems, such as familial hypercholesterolemia, severe cardiovascular and cerebrovascular diseases (e.g., myocardial infarction, stroke, and heart failure), respiratory diseases, infectious diseases, chronic kidney disease, pregnancy, and malignancies